BR0207644A - Compostos de carbamato para uso na prevenção ou no tratamento de distúrbio bipolar - Google Patents

Compostos de carbamato para uso na prevenção ou no tratamento de distúrbio bipolar

Info

Publication number
BR0207644A
BR0207644A BR0207644-6A BR0207644A BR0207644A BR 0207644 A BR0207644 A BR 0207644A BR 0207644 A BR0207644 A BR 0207644A BR 0207644 A BR0207644 A BR 0207644A
Authority
BR
Brazil
Prior art keywords
prevention
treatment
bipolar disorder
carbamate compounds
phenyl
Prior art date
Application number
BR0207644-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Carlos R Plata-Salaman
Boyu Zhao
Roy E Twyman
Yong Moon Choi
Robert Gordon
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of BR0207644A publication Critical patent/BR0207644A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/325Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Hydrogenated Pyridines (AREA)
BR0207644-6A 2001-02-27 2002-02-21 Compostos de carbamato para uso na prevenção ou no tratamento de distúrbio bipolar BR0207644A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27168101P 2001-02-27 2001-02-27
US10/081,766 US6562867B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder
PCT/US2002/005297 WO2002067921A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder

Publications (1)

Publication Number Publication Date
BR0207644A true BR0207644A (pt) 2004-03-09

Family

ID=26765948

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0207644-6A BR0207644A (pt) 2001-02-27 2002-02-21 Compostos de carbamato para uso na prevenção ou no tratamento de distúrbio bipolar

Country Status (26)

Country Link
US (1) US6562867B2 (cg-RX-API-DMAC7.html)
EP (1) EP1408953B1 (cg-RX-API-DMAC7.html)
JP (1) JP4276837B2 (cg-RX-API-DMAC7.html)
KR (1) KR100946944B1 (cg-RX-API-DMAC7.html)
CN (1) CN1250215C (cg-RX-API-DMAC7.html)
AT (1) ATE324108T1 (cg-RX-API-DMAC7.html)
BR (1) BR0207644A (cg-RX-API-DMAC7.html)
CA (1) CA2439475C (cg-RX-API-DMAC7.html)
CY (1) CY1105330T1 (cg-RX-API-DMAC7.html)
CZ (1) CZ20032300A3 (cg-RX-API-DMAC7.html)
DE (1) DE60210976T2 (cg-RX-API-DMAC7.html)
DK (1) DK1408953T3 (cg-RX-API-DMAC7.html)
ES (1) ES2262801T3 (cg-RX-API-DMAC7.html)
HU (1) HUP0303243A3 (cg-RX-API-DMAC7.html)
IL (1) IL157590A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03007717A (cg-RX-API-DMAC7.html)
MY (1) MY129304A (cg-RX-API-DMAC7.html)
NO (1) NO20033802L (cg-RX-API-DMAC7.html)
NZ (1) NZ527988A (cg-RX-API-DMAC7.html)
PL (1) PL364638A1 (cg-RX-API-DMAC7.html)
PT (1) PT1408953E (cg-RX-API-DMAC7.html)
RS (1) RS50677B (cg-RX-API-DMAC7.html)
RU (1) RU2300372C2 (cg-RX-API-DMAC7.html)
TW (1) TWI250872B (cg-RX-API-DMAC7.html)
WO (1) WO2002067921A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200307465B (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ523851A (en) * 2000-07-21 2004-09-24 Ortho Mcneil Pharm Inc A method for use of carbamate enantiomers in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
WO2002067923A1 (en) * 2001-02-27 2002-09-06 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating anxiety disorders
PT1383489E (pt) * 2001-02-27 2007-06-21 Ortho Mcneil Pharm Inc Compostos carbamato para utilização na prevenção ou tratamento de distúrbios neurodegenerativos
BR0211244A (pt) 2001-07-16 2004-07-27 Ortho Mcneil Pharm Inc Compostos de carbamato para uso na prevenção ou tratamento de dor neuropática e dor associada com cefaléia em salvas e enxaqueca
NZ553813A (en) * 2004-09-16 2010-09-30 Janssen Pharmaceutica Nv Use of 2-phenyl-1, 2-ethanediol-(DI) carbamates for treating epileptogenesis and epilepsy
KR101335941B1 (ko) 2005-06-08 2013-12-04 에스케이바이오팜 주식회사 수면-각성 장애의 치료
US20070021501A1 (en) * 2005-07-12 2007-01-25 Twyman Roy E Methods of treating epileptogenesis
BRPI0718324A2 (pt) * 2006-10-30 2013-11-26 Sk Holdings Métodos para o tratamento de depressão.
CN101568333A (zh) * 2006-10-31 2009-10-28 詹森药业有限公司 广泛性发育障碍的治疗
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
KR102014615B1 (ko) * 2013-03-12 2019-08-27 (주)바이오팜솔루션즈 페닐카바메이트 화합물 및 이를 포함하는 신경보호용 조성물
US10195151B2 (en) 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
KR102635938B1 (ko) * 2016-12-14 2024-02-13 에스케이바이오팜 주식회사 양극성 장애의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도
BR112019025286A2 (pt) 2017-06-02 2020-06-23 Jazz Pharmaceuticals Ireland Limited Métodos e composições para tratamento de sonolência excessiva
US10940133B1 (en) 2020-03-19 2021-03-09 Jazz Pharmaceuticals Ireland Limited Methods of providing solriamfetol therapy to subjects with impaired renal function

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
CN1056611C (zh) * 1994-06-16 2000-09-20 美国辉瑞有限公司 吡唑并吡啶和吡咯并吡啶,其用途和用于制备它们的中间体
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Also Published As

Publication number Publication date
CZ20032300A3 (cs) 2005-01-12
YU67803A (sh) 2006-08-17
RS50677B (sr) 2010-06-30
CA2439475A1 (en) 2002-09-06
KR20030087010A (ko) 2003-11-12
HUP0303243A2 (hu) 2004-01-28
MXPA03007717A (es) 2005-11-08
NZ527988A (en) 2006-01-27
IL157590A0 (en) 2004-03-28
EP1408953A1 (en) 2004-04-21
NO20033802L (no) 2003-10-22
ZA200307465B (en) 2005-03-17
WO2002067921A1 (en) 2002-09-06
HK1063436A1 (en) 2004-12-31
US6562867B2 (en) 2003-05-13
DE60210976T2 (de) 2007-05-24
DK1408953T3 (da) 2006-08-21
CN1505506A (zh) 2004-06-16
CN1250215C (zh) 2006-04-12
KR100946944B1 (ko) 2010-03-15
JP4276837B2 (ja) 2009-06-10
HUP0303243A3 (en) 2012-07-30
US20020198257A1 (en) 2002-12-26
RU2003128997A (ru) 2005-03-20
CY1105330T1 (el) 2010-03-03
EP1408953B1 (en) 2006-04-26
MY129304A (en) 2007-03-30
PT1408953E (pt) 2006-07-31
TWI250872B (en) 2006-03-11
ATE324108T1 (de) 2006-05-15
RU2300372C2 (ru) 2007-06-10
PL364638A1 (en) 2004-12-13
JP2004533415A (ja) 2004-11-04
ES2262801T3 (es) 2006-12-01
NO20033802D0 (no) 2003-08-26
CA2439475C (en) 2010-05-18
DE60210976D1 (de) 2006-06-01

Similar Documents

Publication Publication Date Title
BR0207831A (pt) Compostos carbamato para uso na prevenção ou tratamento de distúrbios do movimento
BR0207645A (pt) Compostos carbamato para utilização na prevenção ou tratamento de distúrbios neurodegenerativos
BR0207644A (pt) Compostos de carbamato para uso na prevenção ou no tratamento de distúrbio bipolar
CY1107199T1 (el) Καρβαμικες ενωσεις για χρηση στη προληψη ή τη θεραπευτικη αντιμετωπιση της διπολικης διαταραχης
NO20080877L (no) Fremgangsmater for behandling av substansrelaterte forstyrrelser
BR0207673A (pt) Compostos de carbamato para o uso no tratamento de dor
BR0207829A (pt) Composto de carbamato para uso na prevenção ou tratamento de distúrbios psicóticos
BR0207830A (pt) Compostos de carbamato para uso em prevenir ou tratar distúrbios de ansiedade
BR0112713A (pt) "compostos de carbamato para uso na prevenção ou tratamento de dor neuropática e dor associada a cefaléia em cacho e hemicrânia
BRPI0516112A (pt) métodos para neuroproteção
BR0211240A (pt) Compostos de carbamato para uso na prevenção ou tratamento de dor neuropática e dor associada à cefaléia em cacho e hemicrânia
BR0211244A (pt) Compostos de carbamato para uso na prevenção ou tratamento de dor neuropática e dor associada com cefaléia em salvas e enxaqueca

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Free format text: JOHNSON & JOHNSON (US)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]